Stevanato Group supplies glass primary packaging and drug-delivery systems for the pharmaceutical and biotech industries, including vials, syringes and cartridges. It also offers inspection machines, assembly equipment and analytical services that support sterile fill-finish operations. The company is known for high-precision containment solutions used with injectable drugs and biologics, serving global pharma manufacturers and contract fillers.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q2 2025 | 280 | — | 29.7 | 8.9% |
| Q3 2025 | 303.2 | — | 36.1 | 1.7% |
| Q4 2025 | 346.5 | — | 47.5 | -12.9% |
| Q1 2026 | 273.6 | — | 28 | -6.7% |
| Q2 2026 | 302 | 7.8% | 23 | -22.7% |
All markets — KeepWinning global stock screener
Other companies on NYSE: RLI Corp. (RLI), RingCentral, Inc. (RNG), Virtu Financial, Inc. (VIRT), Associated Banc-Corp (ASB), Companhia Energética de Minas Gerais - CEMIG (CIG), Macy's, Inc. (M)